©istock.com/Andrea Obzerova
Unsere KompetenzInterdisziplinäre Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patientinnen und Patienten.

Klinische FragestellungNeuropathie, hereditäre mit Neigung zu Drucklähmungen - HNPP; Differentialdiagnose

Zusammenfassung

Kurzinformation

Umfassendes differentialdiagnostisches panel für Neuropathie, hereditäre mit Neigung zu Drucklähmungen - HNPP, mit einem Leitlinien-kuratierten "core"-Gen, 7 "core candidate"-Genen und zusammen genommen >100 kuratierten Genen gemäß klinischer Verdachtsdiagnose (weitere CMT-Gene ggf. in DD berücksichtigen)

ID
NP1321
Anzahl Gene
93 Akkreditierte Untersuchung
Untersuchte Sequenzlänge
10,8 kb (Core-/Core-canditate-Gene)
222,8 kb (Erweitertes Panel: inkl. additional genes)
Analyse-Dauer
auf Anfrage
Untersuchungsmaterial
  • EDTA-Blut (3-5 ml)
Diagnostische Hinweise

NGS +

X

 

Genpanel

Ausgewählte Gene

NameExon-Länge (bp)OMIM-GReferenz-Seq.Erbgang
GDAP11077NM_018972.4AD, AR
GJB1852NM_000166.6XL
HINT1381NM_005340.7AR
MFN22274NM_014874.4AR
MPZ747NM_000530.8AD
PMP22483NM_000304.4AD
SH3TC23867NM_024577.4AD, AR
SORD1074NM_003104.6AR
AARS12927NM_001605.3AR
ABCD12238NM_000033.4XLR
ABHD121197NM_001042472.3AR
AIFM11842NM_004208.4XLR
ARSA1530NM_000487.6AR
ATP1A13072NM_000701.8AD
ATP7A4503NM_000052.7XLR
BAG31728NM_004281.4AD
BSCL21197NM_032667.6AD
CADM31309NM_001127173.3AD
CAV3456NM_033337.3AD
CNTNAP14155NM_003632.3AR
COA7699NM_023077.3AR
CRYAB528NM_001885.3n.k.
DCTN13837NM_004082.5AD
DES1413NM_001927.4AD, AR
DGAT21207NM_001253891.2AD
DNAJB2834NM_001039550.2AR
DNAJB6981NM_058246.4AD
DNM22613NM_001005360.3AD
DNMT14899NM_001130823.3AD
DRP22640NM_001171184.2XL
DYNC1H113941NM_001376.5AD
DYSF6243NM_003494.4AR
EGR21431NM_000399.5AD, AR
FGD42301NM_139241.3AR
FIG42724NM_014845.6AR
FLNC8178NM_001458.5AD
FXN633NM_000144.5
GARS12220NM_002047.4AD
GNB41023NM_021629.4AD
GNE2262NM_001128227.3AR
HARS11530NM_002109.6AD
HSPB1618NM_001540.5AD
HSPB8591NM_014365.3AD
IGHMBP22982NM_002180.3AR
INF23750NM_022489.4AD
KIF1B5313NM_015074.3AD
KIF5A3099NM_004984.4AD
LDB3852NM_001080116.1AD
LITAF486NM_004862.4AD
LMNA1995NM_170707.4AR
LRSAM12172NM_138361.5AD, AR
MARS12703NM_004990.3AD, AR
MATR32544NM_199189.3AD
MCM3AP5943NM_003906.5AR
MME2253NM_007289.4AR, AD
MORC23140NM_014941.3AD
MPV17531NM_002437.5AR
MTMR21932NM_016156.6AR
MYH75808NM_000257.4n.k.
MYOT1497NM_006790.3AD
NAGLU2232NM_000263.4AD
NDRG11185NM_006096.4AR
NEFH3063NM_021076.4AD
NEFL1633NM_006158.5AD, AR
PDK31248NM_001142386.3XL
PEX7972NM_000288.4AR
PHYH1017NM_006214.4AR
PLEKHG53189NM_020631.6AR
PLP1834NM_000533.5XLR
PMP2403NM_002677.5AD
PNKP1566NM_007254.4AR
PRPS1957NM_002764.4XL
PRX4386NM_181882.3AR
PTRH2540NM_016077.5AR
RAB7A624NM_004637.6AD
SBF15682NM_002972.4AR
SBF25550NM_030962.4AR
SCN9A5934NM_002977.3AD, AR
SEPTIN92223NM_006640.5AD
SETX8034NM_015046.7AR
SIGMAR1672NM_005866.4AR
SPART2001NM_015087.5AR
SPG117332NM_025137.4AR
SPTLC11422NM_006415.4AD
TCAP504NM_003673.4n.k.
TIA11161NM_022173.4AD
TRIM22235NM_001130067.2AR
TRPV42616NM_021625.5AD
TTR444NM_000371.4AR
TYMP1449NM_001953.5AR
VWA11341NM_022834.5AR
WARS11451AD
YARS11587NM_003680.3AD

Infos zur Erkrankung

Klinischer Kommentar

Die hereditäre Neuropathie mit Neigung zu Drucklähmungen betrifft periphere Nerven. Diese sind ungewöhnlich druckempfindlich. Die Erkrankung ist gekennzeichnet durch wiederkehrende Episoden von Taubheit, Kribbeln und Lähmungen in der Region des betroffenen Nervs (Arm, Hand, Bein, Fuß). Ein Ereignis kann zwischen Minuten und Monaten dauern, die Genesung ist in der Regel vollständig. Schmerzen in den Gliedmaßen, insbesondere in den Händen, treten häufig auf. Viele Betroffene leiden unter einem Karpaltunnel-Syndrom. Die Symptome dieser hereditären Neuropathie beginnen in der Regel in der Jugend oder im frühen Erwachsenenalter, sind unterschiedlich stark ausgeprägt, haben aber keine Auswirkungen auf die Lebenserwartung. Hereditäre Neuropathie mit Neigung zu Drucklähmungen wird am häufigsten durch die Deletion einer Kopie des PMP22-Gens verursacht. Dieser Verlust verringert die Menge des produzierten PMP22-Proteins. Auch andere Mutationen des PMP22-Gens, die zu einer Verringerung des PMP22-Proteins führen, können diese Erkrankung verursachen. Die Vererbung ist autosomal dominant.

Referenz: https://www.ncbi.nlm.nih.gov/books/NBK1392/

 

Synonyme
  • Neuropathy, recurrent, with pressure palsies (PMP22)
  • Alias: Axonal + demyelinating neuropathies
  • Alias: CMT1, CMT2, CMT3, CMTX; HMSNI, HMSNII, HMSNIII ...
  • Alias: Polyneuropathie
  • Allelic: Alpha-aminoadipic + alpha-ketoadipic aciduria (DHTKD1)
  • Allelic: Amyotrophic lateral sclerosis 11 (FIG4)
  • Allelic: Amyotrophic lateral sclerosis 16, juvenile (SIGMAR1)
  • Allelic: Amyotrophic lateral sclerosis 4, juvenile (SETX)
  • Allelic: Amyotrophic lateral sclerosis 5, juvenile (SPG11)
  • Allelic: Amyotrophic lateral sclerosis, susceptibility to (DCTN1)
  • Allelic: Amyotrophic lateral sclerosis, susceptibility to (NEFH)
  • Allelic: Amyotrophic lateral sclerosis, susceptibility to, 25 (KIF5A)
  • Allelic: Arts syndrome (PRPS1)
  • Allelic: Ataxia-oculomotor apraxia 4 (PNKP)
  • Allelic: Avascular necrosis of femoral head, primary, 2 (TRPV4)
  • Allelic: Brachyolmia type 3 (TRPV4)
  • Allelic: Cardiomyopathy, dilated, 1A (LMNA)
  • Allelic: Cardiomyopathy, dilated, 1C, with/-out LVNC (LDB3)
  • Allelic: Cardiomyopathy, dilated, 1G (TTN)
  • Allelic: Cardiomyopathy, dilated, 1HH (BAG3)
  • Allelic: Cardiomyopathy, dilated, 1I (DES)
  • Allelic: Cardiomyopathy, dilated, 1II (CRYAB)
  • Allelic: Cardiomyopathy, dilated, 1S (MYH7)
  • Allelic: Cardiomyopathy, familial hypertrophic (CAV3)
  • Allelic: Cardiomyopathy, familial hypertrophic, 26 (FLNC)
  • Allelic: Cardiomyopathy, familial hypertrophic, 9 (TTN)
  • Allelic: Cardiomyopathy, familial restrictive 5 (FLNC)
  • Allelic: Cardiomyopathy, hypertrophic, 1 (MYH7)
  • Allelic: Cardiomyopathy, hypertrophic, 24 (LDB3)
  • Allelic: Cardiomyopathy, hypertrophic, 25 (TCAP)
  • Allelic: Cataract 16, multiple types (CRYAB)
  • Allelic: Centronuclear myopathy 1 (DNM2)
  • Allelic: Cerebellar ataxia, deafness, and narcolepsy, AD (DNMT1)
  • Allelic: Cortical dysplasia, complex, with other brain malformations 1 (TUBB3)
  • Allelic: Creatine phosphokinase, elevated serum (CAV3)
  • Allelic: Cutis laxa, AD 2 (FBLN5)
  • Allelic: Cutis laxa, AR, type IA (FBLN5)
  • Allelic: Deafness, AR 89 (KARS1)
  • Allelic: Deafness, XL 1 (PRPS1)
  • Allelic: Deafness, XL 5 (AIFM1)
  • Allelic: Deafness, congenital + adult-onset progressive leukoencephalopathy (KARS1)
  • Allelic: Developmental + epileptic encephalopathy 29 (AARS1)
  • Allelic: Digital arthropathy-brachydactyly, familial (TRPV4)
  • Allelic: Dystransthyretinemic hyperthyroxinemia (TTR)
  • Allelic: Emery-Dreifuss muscular dystrophy 2, AD (LMNA)
  • Allelic: Emery-Dreifuss muscular dystrophy 3, AR (LMNA)
  • Allelic: Encephalopathy, progressive, +/- lipodystrophy (BSCL2)
  • Allelic: Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 (CHCHD10)
  • Allelic: Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 (VCP)
  • Allelic: Glomerulosclerosis, focal segmental, 5 (INF2)
  • Allelic: Gnathodiaphyseal dysplasia (ABHD12)
  • Allelic: Gout, PRPS-related (PRPS1)
  • Allelic: Heart-hand syndrome, Slovenian type (LMNA)
  • Allelic: Hemolytic anemia due to hexokinase deficiency (HK1)
  • Allelic: Hutchinson-Gilford progeria (LMNA)
  • Allelic: Hypomagnesemia, seizures + mental retardation 2 (ATP1A1)
  • Allelic: Inclusion body myopathy with early-onset Paget disease + frontotemporal dementia 1 (VCP)
  • Allelic: Infantile-onset multisystem neurologic, endocrine + pancreatic disease 2 (YARS1)
  • Allelic: Interstitial lung + liver disease (MARS1)
  • Allelic: Left ventricular noncompaction 3 (LDB3)
  • Allelic: Left ventricular noncompaction 5 (MYH7)
  • Allelic: Lethal congenital contracture syndrome 5 (DNM2)
  • Allelic: Leukoencephalopathy, progressive, infantile-onset, with/-out deafness (KARS1)
  • Allelic: Lipodystrophy, congenital generalized, type 2 (BSCL2)
  • Allelic: Lipodystrophy, familial partial, type 2 (LMNA)
  • Allelic: Long QT syndrome 9 (CAV3)
  • Allelic: Macular degeneration, age-related, 3 (FBLN5)
  • Allelic: Malouf syndrome (LMNA)
  • Allelic: Mandibuloacral dysplasia (LMNA)
  • Allelic: Medulloblastoma (ELP1)
  • Allelic: Menkes disease (ATP7A)
  • Allelic: Mental retardation, AD 13 (DYNC1H1)
  • Allelic: Metatropic dysplasia (TRPV4)
  • Allelic: Microcephaly, seizures, developmental delay (PNKP)
  • Allelic: Mitochondrial DNA depletion syndrome 6 [hepatocerebral type] (MPV17)
  • Allelic: Mononeuropathy of the median nerve, mild (SH3TC2)
  • Allelic: Mucopolysaccharidosis type IIIB [Sanfilippo B] (NAGLU)
  • Allelic: Muscular dystrophy, congenital (LMNA)
  • Allelic: Muscular dystrophy, limb-girdle, AR 12 (ANO5)
  • Allelic: Myoclonus, intractable, neonatal (KIF5A)
  • Allelic: Myopathy, isolated mitochondrial, AD (CHCHD10)
  • Allelic: Myopathy, myofibrillar, 6 (BAG3)
  • Allelic: Myopia 6 (SCO2)
  • Allelic: NESCAV syndrome (KIF1A)
  • Allelic: Neuroblastoma, susceptibility to, 1 (KIF1B)
  • Allelic: Neurodevelopmental disorder with visual defects + brain anomalies (HK1)
  • Allelic: Occipital horn syndrome (ATP7A)
  • Allelic: Parastremmatic dwarfism (TRPV4)
  • Allelic: Perry syndrome (DCTN1)
  • Allelic: Pheochromocytoma (KIF1B)
  • Allelic: Phosphoribosylpyrophosphate synthetase superactivity (PRPS1)
  • Allelic: Polymicrogyria, bilateral temporooccipital (FIG4)
  • Allelic: Restrictive dermopathy, lethal (LMNA)
  • Allelic: Retinitis pigmentosa 79 (HK1)
  • Allelic: Rhizomelic chondrodysplasia punctata, type 1 (PEX7)
  • Allelic: Roussy-Levy syndrome (MPZ, PMP22)
  • Allelic: Scapuloperoneal spinal muscular atrophy (TRPV4)
  • Allelic: Sialuria (GNE)
  • Allelic: Silver spastic paraplegia syndrome (BSCL2)
  • Allelic: Sodium serum level QTL 1 (TRPV4)
  • Allelic: Spastic paraplegia 10, AD (KIF5A)
  • Allelic: Spastic paraplegia 11, AR (SPG11)
  • Allelic: Spastic paraplegia 30, AD (KIF1A)
  • Allelic: Spastic paraplegia 57, AR (TFG)
  • Allelic: Spinal muscular atrophy, distal, AR, 4 (PLEKHG5)
  • Allelic: Spinal muscular atrophy, distal, AR, 5 (DNAJB2)
  • Allelic: Spinal muscular atrophy, infantile, James type (GARS1)
  • Allelic: Spinal muscular atrophy, lower extremity-predominant 1, AD (DYNC1H1)
  • Allelic: Spinocerebellar ataxia 43 (MME)
  • Allelic: Spondyloepimetaphyseal dysplasia, Maroteaux type (TRPV4)
  • Allelic: Spondyloepimetaphyseal dysplasia, XL, with hypomyelinating leukodystrophy (AIFM1)
  • Allelic: Spondylometaphyseal dysplasia, Kozlowski type (TRPV4)
  • Allelic: Usher syndrome type 3B (HARS1)
  • Allelic: Yunis-Varon syndrome (FIG4)
  • Adrenoleukodystrophy (ABCD1)
  • Adrenomyeloneuropathy, adult (ABCD1)
  • Allelic: Epidermolysis bullosa simplex 3, localized/generalized intermediate, bp230 deficiency (DST)
  • Allelic: Mitochondrial complex IV deficiency, nuclear type 1 (SURF1)
  • Amyloidosis, hereditary, transthyretin-related (TTR)
  • Amyotrophic lateral sclerosis 21 (MATR3)
  • Amyotrophic lateral sclerosis 26 with/-out frontotemporal dementia (TIA1)
  • Amyotrophy, hereditary neuralgic (SEPTIN9)
  • Basel-Vanagait-Smirin-Yosef syndrome (MED25)
  • Carpal tunnel syndrome, familial (TTR)
  • Charcot-Marie-Tooth disease, XLD, 6 (PDK3)
  • Charcot-Marie-Tooth disease, XLR, 5 (PRPS1)
  • Charcot-Marie-Tooth disease, axonal type 2A2A (MFN2)
  • Charcot-Marie-Tooth disease, axonal type 2A2B (MFN2)
  • Charcot-Marie-Tooth disease, axonal type 2CC (NEFH)
  • Charcot-Marie-Tooth disease, axonal type 2DD (ATP1A1)
  • Charcot-Marie-Tooth disease, axonal type 2EE (MPV17)
  • Charcot-Marie-Tooth disease, axonal type 2F (HSPB1)
  • Charcot-Marie-Tooth disease, axonal type 2K (GDAP1)
  • Charcot-Marie-Tooth disease, axonal type 2L (HSPB8)
  • Charcot-Marie-Tooth disease, axonal type 2M (DNM2)
  • Charcot-Marie-Tooth disease, axonal type 2N (AARS1)
  • Charcot-Marie-Tooth disease, axonal type 2O (DYNC1H1)
  • Charcot-Marie-Tooth disease, axonal type 2P (LRSAM1)
  • Charcot-Marie-Tooth disease, axonal type 2Q (DHTKD1)
  • Charcot-Marie-Tooth disease, axonal type 2R (TRIM2)
  • Charcot-Marie-Tooth disease, axonal type 2S (IGHMBP2)
  • Charcot-Marie-Tooth disease, axonal type 2T (MME)
  • Charcot-Marie-Tooth disease, axonal type 2U (MARS)
  • Charcot-Marie-Tooth disease, axonal type 2V (NAGLU)
  • Charcot-Marie-Tooth disease, axonal type 2W (HARS1)
  • Charcot-Marie-Tooth disease, axonal type 2X (SPG11)
  • Charcot-Marie-Tooth disease, axonal type 2Z (MORC2)
  • Charcot-Marie-Tooth disease, axonal with vocal cord paresis (GDAP1)
  • Charcot-Marie-Tooth disease, axonal, type 2FF (CADM3)
  • Charcot-Marie-Tooth disease, demyelinating type 1G (PMP2)
  • Charcot-Marie-Tooth disease, demyelinating, type 1H (FBLN5)
  • Charcot-Marie-Tooth disease, dominant intermediate B (DNM2)
  • Charcot-Marie-Tooth disease, dominant intermediate C (YARS1)
  • Charcot-Marie-Tooth disease, dominant intermediate D (MPZ)
  • Charcot-Marie-Tooth disease, dominant intermediate E (INF2)
  • Charcot-Marie-Tooth disease, dominant intermediate F (GNB4)
  • Charcot-Marie-Tooth disease, dominant intermediate G (NEFL)
  • Charcot-Marie-Tooth disease, recessive intermediate A (GDAP1)
  • Charcot-Marie-Tooth disease, recessive intermediate B (KARS1)
  • Charcot-Marie-Tooth disease, recessive intermediate C (PLEKHG5)
  • Charcot-Marie-Tooth disease, recessive intermediate D (COX6A1)
  • Charcot-Marie-Tooth disease, type 1A (PMP22)
  • Charcot-Marie-Tooth disease, type 1B (MPZ)
  • Charcot-Marie-Tooth disease, type 1C (LITAF)
  • Charcot-Marie-Tooth disease, type 1D (EGR2)
  • Charcot-Marie-Tooth disease, type 1E (PMP22)
  • Charcot-Marie-Tooth disease, type 1F (NEFL)
  • Charcot-Marie-Tooth disease, type 2A1 (KIF1B)
  • Charcot-Marie-Tooth disease, type 2B (RAB7A)
  • Charcot-Marie-Tooth disease, type 2B1 (LMNA)
  • Charcot-Marie-Tooth disease, type 2B2 (PNKP)
  • Charcot-Marie-Tooth disease, type 2D (GARS1)
  • Charcot-Marie-Tooth disease, type 2E (NEFL)
  • Charcot-Marie-Tooth disease, type 2I (MPZ)
  • Charcot-Marie-Tooth disease, type 2J (MPZ)
  • Charcot-Marie-Tooth disease, type 2R (TRIM2)
  • Charcot-Marie-Tooth disease, type 2Y (VCP)
  • Charcot-Marie-Tooth disease, type 4A (GDAP1)
  • Charcot-Marie-Tooth disease, type 4B1 (MTMR2)
  • Charcot-Marie-Tooth disease, type 4B2 (SBF2)
  • Charcot-Marie-Tooth disease, type 4B3 (SBF1)
  • Charcot-Marie-Tooth disease, type 4C (SH3TC2)
  • Charcot-Marie-Tooth disease, type 4D (NDRG1)
  • Charcot-Marie-Tooth disease, type 4F (PRX)
  • Charcot-Marie-Tooth disease, type 4H (FGD4)
  • Charcot-Marie-Tooth disease, type 4J (FIG4)
  • Charcot-Marie-Tooth disease, type 4K (SURF1)
  • Charcot-Marie-Tooth neuropathy, XLD, 1 (GJB1)
  • Combined oxidative phosphorylation deficiency 6 (AIFM1)
  • Congenital cataracts, facial dysmorphism + neuropathy (CTDP1)
  • Cowchock syndrome (AIFM1)
  • Dejerine-Sottas disease (EGR2, MPZ, PMP22, PRX)
  • Dejerine-Sottas disease (PMP22)
  • Dent disease 2 (OCRL)
  • Developmental delay, impaired growth, dysmorphic facies + axonal neuropathy (MORC2)
  • Dysautonomia, familial (ELP1)
  • Erythermalgia, primary (SCN9A)
  • Fibrosis of extraocular muscles, congenital, 3A (TUBB3)
  • Friedreich ataxia (FXN)
  • Friedreich ataxia with retained reflexes (FXN)
  • Giant axonal neuropathy-1, AR (GAN)
  • Giant axonal neuropathy-2, AD (DCAF8)
  • Hereditary Neuropathies [panelapp] (KIF5A)
  • Hereditary motor + sensory neuropathy VIA (MFN2)
  • Hereditary motor + sensory neuropathy, Okinawa type (TFG)
  • Hereditary motor + sensory neuropathy, type IIc (TRPV4)
  • Hypomyelinating neuropathy, congenital, 1 (EGR2)
  • Hypomyelinating neuropathy, congenital, 2 (MPZ)
  • Hypomyelinating neuropathy, congenital, 3 (CNTNAP1)
  • Infantile-onset multisystem neurologic, endocrine + pancreatic disease (PTRH2)
  • Insensitivity to pain, congenital (SCN9A)
  • Laing distal myopathy (MYH7)
  • Lethal congenital contracture syndrome 7 (CNTNAP1)
  • Lowe syndrome (OCRL)
  • Metachromatic leukodystrophy (ARSA)
  • Mitochondrial DNA depletion syndrome 1 [MNGIE type] (TYMP)
  • Mitochondrial complex IV deficiency, nuclear type 2 (SCO2)
  • Miyoshi muscular dystrophy 1 (DYSF)
  • Miyoshi muscular dystrophy 3 (ANO5)
  • Muscular dystrophy, limb-girdle, AD 1 (DNAJB6)
  • Muscular dystrophy, limb-girdle, AR 10 (TTN)
  • Muscular dystrophy, limb-girdle, AR 2 (DYSF)
  • Muscular dystrophy, limb-girdle, AR 7 (TCAP)
  • Myopathy, distal, 4 (FLNC)
  • Myopathy, distal, Tateyama type (CAV3)
  • Myopathy, distal, with anterior tibial onset (DYSF)
  • Myopathy, myofibrillar, 1 (DES)
  • Myopathy, myofibrillar, 2 (CRYAB)
  • Myopathy, myofibrillar, 3 (MYOT)
  • Myopathy, myofibrillar, 4 (LDB3)
  • Myopathy, myofibrillar, 5 (FLNC)
  • Myopathy, myofibrillar, 9, with early respiratory failure (TTN)
  • Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related (CRYAB)
  • Myopathy, myosin storage, AD + AR (MYH7)
  • Myopathy, spheroid body (MYOT)
  • Nemaline myopathy 2, AR (NEB)
  • Nephrotic syndrome, type 14 (SGPL1)
  • Neurodevelopmental disorder with microcephaly, ataxia, seizures (SARS1)
  • Neuromyotonia and axonal neuropathy, AR (HINT1)
  • Neuronopathy, distal hereditary motor, type IIA (HSPB8)
  • Neuronopathy, distal hereditary motor, type IIB (HSPB1)
  • Neuronopathy, distal hereditary motor, type IIC (HSPB3)
  • Neuronopathy, distal hereditary motor, type IX (WARS1)
  • Neuronopathy, distal hereditary motor, type VA (GARS1)
  • Neuronopathy, distal hereditary motor, type VI (IGHMBP2)
  • Neuronopathy, distal hereditary motor, type VIIB (DCTN1)
  • Neuronopathy, distal hereditary motor, type VIII (TRPV4)
  • Neuropathy, axonal [GeneReviews] (DGAT2)
  • Neuropathy, distal hereditary motor, type VC (BSCL2)
  • Neuropathy, hereditary motor + myopathic features (VWA1)
  • Neuropathy, hereditary motor + sensory, Russe type (HK1)
  • Neuropathy, hereditary motor + sensory, type VIB (SLC25A46)
  • Neuropathy, hereditary sensory + autonomic, type IA (SPTLC1)
  • Neuropathy, hereditary sensory + autonomic, type IID (SCN9A)
  • Neuropathy, hereditary sensory + autonomic, type V (NGF)
  • Neuropathy, hereditary sensory + autonomic, type VI (DST)
  • Neuropathy, hereditary sensory + autonomic, type VIII (PRDM12)
  • Neuropathy, hereditary sensory, type IE (DNMT1)
  • Neuropathy, hereditary sensory, type IIC (KIF1A)
  • Neuropathy, hereditary, +/- age-related macular degeneration (FBLN5)
  • Neuropathy, inflammatory demyelinating (PMP22)
  • Neuropathy, intermediate [GeneReviews] (DRP2)
  • Neuropathy, recurrent, with pressure palsies (PMP22)
  • Nonaka myopathy (GNE)
  • Paroxysmal extreme pain disorder (SCN9A)
  • Pelizaeus-Merzbacher disease (PLP1)
  • Peripheral neuropathy, AR, +/- impaired intellectual development (MCM3AP)
  • Peroxisome biogenesis disorder 9B (PEX7)
  • Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, + cataract (ABHD12)
  • Pontocerebellar hypoplasia, type 1E (SLC25A46)
  • Refsum disease (PHYH)
  • Rippling muscle disease 2 (CAV3)
  • Roussy-Levy syndrome (PMP22)
  • Salih myopathy (TTN)
  • Scapuloperoneal syndrome, myopathic type (MYH7)
  • Scapuloperoneal syndrome, neurogenic, Kaeser type (DES)
  • Slowed nerve conduction velocity, AD (ARHGEF10)
  • Small fiber neuropathy (SCN9A)
  • Sorbitol dehydrogenase deficiency with peripheral neuropathy (SORD)
  • Spastic paraplegia 2, XL (PLP1)
  • Spinal muscular atrophy, Jokela type (CHCHD10)
  • Spinal muscular atrophy, distal, AR, 2 (SIGMAR1)
  • Spinal muscular atrophy, distal, XL (ATP7A)
  • Spinocerebellar ataxia, AR, with axonal neuropathy 2 (SETX)
  • Spinocerebellar ataxia, AR, with axonal neuropathy 3 (COA7)
  • Tibial muscular dystrophy, tardive (TTN)
  • Troyer syndrome (SPART)
  • Vocal cord paresis [GeneReviews: as the first manifestation of CMT] (DCTN2)
  • Welander distal myopathy (TIA1)
Erbgänge, Vererbungsmuster etc.
  • AD
  • AR
  • XL
  • XLR
  • n.k.
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatik und klinische Interpretation

Kein Text hinterlegt